ESI研究前沿（Research Fronts）是利用共被引分析（Co-citation Analysis，即多篇论文被同一批其他论文频繁引用）对近五年ESI高被引论文标题中的主要关键词聚类分析而形成的知识群组。全球研究者作为科学共同体，因探究某一科学问题而产生关联，揭示出新兴的、前沿的研究方向。
| Research Fields | Research Fronts | Top Papers | Mean Year | |
| Pharmacology & Toxicology | 1 | AGE-RELATED MACULAR DEGENERATION <I>A RANDOMIZED PIVOTAL PHASE 2</I>/<I>3 TRIAL</I>;AGE-RELATED MACULAR DEGENERATION <I>A RANDOMIZED PHASE 2 TRIAL</I>;REPORTING NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DATA CONSENSUS;NEOVASCULAR AGE-RELATED MACULAR DEGENERATION NOMENCLATURE;NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (TENAYA | 46 | 2022.1 |
| 2 | PLANT-DERIVED EXOSOME-LIKE NANOPARTICLES (PDENS);PLANT-DERIVED EXOSOME-LIKE NANOPARTICLES;PLANT-DERIVED EXOSOME-LIKE NANOVESICLES;GARLIC-DERIVED EXOSOME-LIKE NANOVESICLES ALLEVIATE DEXTRAN SULPHATE SODIUM-INDUCED MOUSE COLITIS <I>VIA</I>;STRAWBERRY-DERIVED EXOSOME-LIKE NANOPARTICLES PREVENT OXIDATIVE STRESS | 41 | 2022.6 | |
| 3 | CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII-CALCOACETICUS COMPLEX INFECTIONS;ANTIMICROBIAL RESISTANT GRAM-NEGATIVE INFECTIONS;DIFFERENT CARBAPENEM-RESISTANT GRAM-NEGATIVE BACILLI;CARBAPENEM-RESISTANT GRAM-NEGATIVE BACILLI;CARBAPENEM-RESISTANT BACTERIAL INFECTIONS | 38 | 2022.5 | |
| 4 | FIBROBLAST ACTIVATION PROTEIN-SPECIFIC PET/CT IMAGING;ALBUMIN BINDER-CONJUGATED FIBROBLAST ACTIVATION PROTEIN INHIBITOR RADIOPHARMACEUTICALS;FIBROBLAST ACTIVATION PROTEIN-TARGETED RADIONUCLIDE THERAPY;FIBROBLAST ACTIVATION PROTEIN-TARGETED PET/CT;EVANS BLUE-MODIFIED RADIOLABELED FIBROBLAST ACTIVATION PROTEIN INHIBITOR | 35 | 2022 | |
| 4 | LANTHANIDE MOFS BASED PORTABLE FLUORESCENCE SENSING PLATFORM;EFFICIENT COPPER(II) SALAMO-BASED COMPLEX FLUORESCENCE CHEMOSENSOR;ULTRASONIC-ASSISTED ENZYMATIC EXTRACTION;HIGHLY SELECTIVE FLUORESCENCE DETECTION;ULTRASOUND-ASSISTED EXTRACTION | 35 | 2023 | |
| 6 | EXTENDED-DURATION SHORT INTERFERING RNA TARGETING LIPOPROTEIN(A);SHORT INTERFERING RNA TARGETING LIPOPROTEIN(A) PRODUCTION;LONG-DURATION SMALL INTERFERING RNA TARGETING LIPOPROTEIN(A);SHORT INTERFERING RNA TARGETING LIPOPROTEIN(A);ZERLASIRAN-A SMALL-INTERFERING RNA TARGETING LIPOPROTEIN(A) | 25 | 2022.6 | |
| 7 | CARBAPENEM-RESISTANT HYPERVIRULENT <I>KLEBSIELLA PNEUMONIAE</I>;CARBAPENEM-RESISTANT <I>KLEBSIELLA PNEUMONIAE</I> COMPLEX;HIGH RISK CARBAPENEM-RESISTANT <I>KLEBSIELLA PNEUMONIAE</I> SUBCLONES;CARBAPENEM-RESISTANT <I>KLEBSIELLA PNEUMONIAE</I> CAPSULAR TYPES;CARBAPENEM-RESISTANT <I>KLEBSIELLA PNEUMONIAE</I> | 23 | 2021.9 | |
| 8 | REDUCE ENTERIC METHANE PRODUCTION;RED SEAWEED <I>(ASPARAGOPSIS TAXIFORMIS)</I> SUPPLEMENTATION REDUCES ENTERIC METHANE;</I> CURRENT ENTERIC METHANE MITIGATION OPTIONS;ENTERIC METHANE MITIGATION;METHANE PRODUCTION | 22 | 2021.4 | |
| 9 | CLINICAL TRIAL COMPARING REMIMAZOLAM;RANDOMIZED NON-INFERIORITY TRIAL;RANDOMIZED NONINFERIORITY TRIAL;PHASE 3 CLINICAL TRIAL;DEXMEDETOMIDINE <I>VERSUS</I> PROPOFOL SEDATION | 21 | 2022.5 | |
| 10 | STRUCTURAL ELUCIDATION DFT CALCULATION;NEW MIXED LIGANDS COMPLEXES BASED;MOLECULAR DOCKING APPROACH;CU(II)-MOXIFLOXACIN-TRI-SUBSTITUTED IMIDAZOLE MIXED LIGAND COMPLEXES;MIXED LIGAND COMPLEXES | 20 | 2023.8 | |
| Biology & Biochemistry | 1 | SPATIAL TRANSCRIPTOMICS DATA;SPATIAL TRANSCRIPTOMICS ENABLES PROBABILISTIC INFERENCE;HIGHLY SENSITIVE SPATIAL TRANSCRIPTOMICS;DECONVOLUTE SPATIAL TRANSCRIPTOMICS SPOTS;MICROARRAY-BASED SPATIAL TRANSCRIPTOMICS | 50 | 2021.8 |
| 2 | MULTIPLE SEGMENTS (DIMS) SPECTACLE LENSES SLOW MYOPIA PROGRESSION;MYOPIA CONTROL EFFECT;ONE-YEAR MYOPIA CONTROL EFFICACY;MYOPIA PROGRESSION (LAMP);MYOPIA CONTROL | 46 | 2021.9 | |
| 3 | MITOCHONDRIAL COPPER DEPLETION SUPPRESSES TRIPLE-NEGATIVE BREAST CANCER;COPPER IONOPHORE TARGETING MITOCHONDRIAL METABOLISM;CUPROPTOSIS-PROMOTED CANCER SYNERGISTIC THERAPY;CUPROPTOSIS-BASED SYNERGISTIC CANCER THERAPY;COPPER METABOLISM | 43 | 2022.2 | |
| 4 | PROLONGED HYPOTHERMIC MACHINE PERFUSION ENABLES DAYTIME LIVER TRANSPLANTATION;NORMOTHERMIC MACHINE PERFUSION ENABLES SAFE TRANSPLANTATION;EXTENDED CRITERIA DONOR LIVER TRANSPLANTATION-A RANDOMIZED CLINICAL TRIAL;EXTENDED CRITERIA DONATION LIVER TRANSPLANTATION;HYPOTHERMIC OXYGENATED MACHINE PERFUSION REDUCES EARLY ALLOGRAFT INJURY | 42 | 2022.6 | |
| 5 | PLANT-DERIVED EXOSOME-LIKE NANOPARTICLES (PDENS);PLANT-DERIVED EXOSOME-LIKE NANOPARTICLES;PLANT-DERIVED EXOSOME-LIKE NANOVESICLES;GARLIC-DERIVED EXOSOME-LIKE NANOVESICLES ALLEVIATE DEXTRAN SULPHATE SODIUM-INDUCED MOUSE COLITIS <I>VIA</I>;STRAWBERRY-DERIVED EXOSOME-LIKE NANOPARTICLES PREVENT OXIDATIVE STRESS | 41 | 2022.6 | |
| 6 | ANAPLASTIC THYROID CANCER AMERICAN THYROID ASSOCIATION ANAPLASTIC THYROID CANCER GUIDELINES TASK FORCE;RET FUSION-POSITIVE NON-SMALL-CELL LUNG CANCER (ARROW);<I>RET</I> FUSION-POSITIVE NON-SMALL-CELL LUNG CANCER INCLUDING;<I>RET</I> FUSION-POSITIVE NON-SMALL-CELL LUNG CANCER;<I>ROS1</I> FUSION-POSITIVE NON-SMALL-CELL LUNG CANCER | 35 | 2021.3 | |
| 7 | HIGHLY EFFICIENT ADSORPTION;EFFICIENT ADSORPTION;EFFECTIVE ADSORPTION;METAL ORGANIC FRAMEWORK ALGINATE AEROGEL COMPOSITE SPONGE;ADSORPTION ISOTHERM | 33 | 2023.5 | |
| 8 | EDIBLE FOOD PACKAGING FILMS;BIO-BASED ACTIVE FOOD PACKAGING MATERIALS;ACTIVE FOOD PACKAGING APPLICATIONS;PECTIN-BASED ACTIVE EDIBLE COATINGS;ANTIMICROBIAL EDIBLE FILMS | 31 | 2021.1 | |
| 9 | PHOTODYNAMIC ANTIBACTERIAL CHITOSAN/NITROGEN-DOPED CARBON DOTS COMPOSITE PACKAGING FILM;HIGH-PERFORMANCE CARBOXYMETHYL STARCH/PVA BASED INTELLIGENT PACKAGING FILMS ENGINEERED;MULTIFUNCTIONAL CARBON DOTS REINFORCED GELATIN-BASED COATING FILM;ACTIVE FOOD PACKAGING APPLICATIONS;INTELLIGENT PACKAGING FILMS BASED | 29 | 2023.3 | |
| 9 | MRNA LIPID NANOPARTICLES;LIPID NANOPARTICLES ENABLES ANTITHROMBIN GENE EDITING;SELECTIVE ORGAN-TARGETING (SORT) LIPID NANOPARTICLES (LNPS);ENGINEERED IONIZABLE LIPID NANOPARTICLES;TISSUE-SPECIFIC MRNA DELIVERY | 29 | 2021.3 | |
| Neuroscience & Behavior | 1 | EVALUATING GLYMPHATIC SYSTEM FUNCTION;GLYMPHATIC SYSTEM IMPAIRMENT;GLYMPHATIC SYSTEM DYSFUNCTION;GLYMPHATIC SYSTEM ALTERATIONS;IMPAIRED GLYMPHATIC SYSTEM | 47 | 2022.2 |
| 2 | MULTIPLE SEGMENTS (DIMS) SPECTACLE LENSES SLOW MYOPIA PROGRESSION;MYOPIA CONTROL EFFECT;ONE-YEAR MYOPIA CONTROL EFFICACY;MYOPIA PROGRESSION (LAMP);MYOPIA CONTROL | 46 | 2021.9 | |
| 3 | HUMAN BRAIN NETWORKS;LOCAL DYNAMIC SPONTANEOUS BRAIN ACTIVITY CHANGES;MACROSCALE BRAIN NETWORKS;GLOBAL BRAIN DISORDER;BRAIN MAPS | 34 | 2021.5 | |
| 4 | COVID-19 ANOSMIA REPORTING TOOL;DECEASED COVID-19 PATIENTS;COVID-19 PATIENTS;HUMAN COVID-19 BRAINS;OLFACTORY SYSTEM SUGGESTS MECHANISMS UNDERLYING COVID-19-ASSOCIATED ANOSMIA | 32 | 2020.3 | |
| 5 | ALZHEIMERS DISEASE PLASMA BIOMARKERS;PLASMA PHOSPHORYLATED TAU 181;PLASMA PHOSPHORYLATED TAU 217;PLASMA PHOSPHORYLATED TAU SPECIES;INCIPIENT ALZHEIMERS DISEASE PATHOLOGY | 31 | 2021.4 | |
| 6 | POSTOPERATIVE DELIRIUM PREVENTION;POSTOPERATIVE DELIRIUM;DELIRIUM PREVENTION;DELIRIUM;ELDERLY TYPE 2 DIABETES MELLITUS | 29 | 2022.1 | |
| 7 | HER2-POSITIVE METASTATIC BREAST CANCER PREVIOUSLY;HER2-LOW ADVANCED BREAST CANCER;HER2-POSITIVE METASTATIC BREAST CANCER;HER2-LOW NON-METASTATIC BREAST CANCER;HER2-LOW BREAST CANCER | 28 | 2021.3 | |
| 8 | CEREBROSPINAL FLUID ALPHA-SYNUCLEIN SEED AMPLIFICATION ASSAY;Α-SYNUCLEIN SEED AMPLIFICATION ASSAY;CSF Α-SYNUCLEIN SEED AMPLIFICATION KINETIC PROFILES;Α-SYNUCLEIN SEED AMPLIFICATION ASSAYS;QUANTITATIVE LEWY-FOLD-SPECIFIC ALPHA-SYNUCLEIN SEED AMPLIFICATION ASSAY | 27 | 2022.4 | |
| 8 | MINOR NONDISABLING ACUTE ISCHEMIC STROKE;ACUTE ISCHEMIC STROKE (CERTAIN) COLLABORATION;ACUTE ISCHEMIC STROKE;ACUTE ISCHAEMIC STROKE;LARGE VESSEL OCCLUSION ISCHEMIC STROKE | 27 | 2022.8 | |
| 10 | CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY;B CELL-TARGETING CHIMERIC ANTIGEN RECEPTOR T CELLS;ANTI-CD19 CAR T CELL THERAPY;REGULATORY T CELLS EXPRESSING CD19-TARGETED CHIMERIC ANTIGEN RECEPTOR RESTORE HOMEOSTASIS;CD19 CHIMERIC ANTIGEN RECEPTOR T CELL TREATMENT | 25 | 2023.9 | |
| Social Sciences, General | 1 | RETHINKING METAVERSE TOURISM;METAVERSE TOURISM;METAVERSE TRAVEL EXPERIENCE;METAVERSE ENGAGEMENT MODEL;METAVERSE MARKETING | 49 | 2023 |
| 2 | UK COVID-19 MENTAL HEALTH & WELLBEING;EARLY COVID-19 PANDEMIC;COVID-19 PANDEMIC LOCKDOWNS;COVID-19 PANDEMIC;COVID-19 PSYCHOLOGICAL WELLBEING | 47 | 2020.9 | |
| 3 | MULTIPLE SEGMENTS (DIMS) SPECTACLE LENSES SLOW MYOPIA PROGRESSION;MYOPIA CONTROL EFFECT;ONE-YEAR MYOPIA CONTROL EFFICACY;MYOPIA PROGRESSION (LAMP);MYOPIA CONTROL | 46 | 2021.9 | |
| 4 | PHYSICAL ACTIVITY MODERATED;SOCIAL NETWORK SITE ADDICTION;PHYSICAL ACTIVITY INTERVENTIONS;SOCIAL NETWORK SITES ADDICTION;SOCIAL NETWORK ADDICTION | 45 | 2024.3 | |
| 4 | AI TECHNOLOGY INTEGRATION AFFECT EMPLOYEES PROACTIVE SERVICE BEHAVIORS;HUMAN-ARTIFICIAL INTELLIGENCE COLLABORATION IMPACTS EMPLOYEES WORK-LIFE-RELATED OUTCOMES;SERVICE EMPLOYEES AI AWARENESS;ARTIFICIAL INTELLIGENCE (AI) AWARENESS;HOTEL FRONTLINE EMPLOYEES USE SERVICE ROBOTS | 45 | 2023 | |
| 6 | TRAVELERS TRUST INTELLIGENT SERVICE ROBOTS;SOCIAL SERVICE ROBOTS;ARTIFICIALLY INTELLIGENT SERVICE ROBOTS;TOURISM SERVICE ROBOTS;USE SERVICE ROBOTS | 43 | 2021 | |
| 7 | DIGITAL TRANSFORMATION PROHIBIT CORPORATE FRAUD;DIGITAL FINANCE DEVELOPMENT;CORPORATE ESG PERFORMANCE AFFECT BOND CREDIT SPREADS;GREEN FINANCE FACILITATE FIRMS;CORPORATE GREEN INNOVATION | 35 | 2023.1 | |
| 7 | AUTISM RESEARCH;AUTISM;AUTISM RESEARCH PRIORITIES;AUTISM EARLY INTERVENTION RESEARCH;AUTISM RESEARCH | 35 | 2021.5 | |
| 9 | UNPACKING CHINESE EFL STUDENTS ACADEMIC ENGAGEMENT;FOSTER CHINESE EFL STUDENTS ACADEMIC ENGAGEMENT;EXPLORING CHINESE EFL LEARNERS ENGAGEMENT;EFL STUDENTS ACADEMIC ENGAGEMENT;CHINESE EFL TEACHERS PERCEPTIONS | 33 | 2024 | |
| 9 | CLIMATE POLICY UNCERTAINTY AFFECT GREEN TECHNOLOGY INNOVATION;GLOBAL CLIMATE POLICY UNCERTAINTY;NEWS-BASED CLIMATE POLICY UNCERTAINTY INDEX;CLIMATE POLICY UNCERTAINTY;POLICY UNCERTAINTY | 33 | 2023.2 | |
| 9 | GREEN FINANCE DEVELOPMENT GOALS AFFECTS RENEWABLE ENERGY;GREEN INDUSTRIAL POLICY ENCOURAGE GREEN INNOVATION;GREEN ECONOMIC GROWTH;RENEWABLE ENERGY GROWTH;RENEWABLE ENERGY DEVELOPMENT | 33 | 2023.6 | |
| Immunology | 1 | MONKEYPOX VIRUS (MPXV) 2022 OUTBREAK;CONFIRMED HUMAN MONKEYPOX VIRUS CASES;HUMAN MONKEYPOX VIRUS INFECTION;ONGOING MONKEYPOX VIRUS OUTBREAK;MONKEYPOX VIRUS OUTBREAK | 45 | 2022.6 |
| 2 | RESPIRATORY SYNCYTIAL VIRUS LOWER RESPIRATORY TRACT INFECTIONS;RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F PROTEIN VACCINE (RSVPREF3 OA);RESPIRATORY SYNCYTIAL VIRUS PREFUSION F PROTEIN VACCINE;PREFUSION F PROTEIN-BASED RESPIRATORY SYNCYTIAL VIRUS IMMUNIZATION;RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED ACUTE RESPIRATORY INFECTION | 40 | 2023 | |
| 3 | PREVIOUSLY UNTREATED METASTATIC NONSQUAMOUS NON-SMALL-CELL LUNG CANCER;ADVANCED NONSQUAMOUS NON-SMALL-CELL LUNG CANCER;ADVANCED SQUAMOUS NON-SMALL-CELL LUNG CANCER;MYSTIC PHASE 3 RANDOMIZED CLINICAL TRIAL;METASTATIC NON-SMALL-CELL LUNG CANCER (GEMSTONE-302) | 39 | 2021.7 | |
| 4 | CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII-CALCOACETICUS COMPLEX INFECTIONS;ANTIMICROBIAL RESISTANT GRAM-NEGATIVE INFECTIONS;DIFFERENT CARBAPENEM-RESISTANT GRAM-NEGATIVE BACILLI;CARBAPENEM-RESISTANT GRAM-NEGATIVE BACILLI;CARBAPENEM-RESISTANT BACTERIAL INFECTIONS | 38 | 2022.5 | |
| 5 | ADVANCED MISMATCH REPAIR-DEFICIENT ENDOMETRIAL CANCER;MICROSATELLITE INSTABILITY-HIGH ADVANCED ENDOMETRIAL CANCER;ADVANCED ENDOMETRIAL CANCER;CORPUS-CONFINED ENDOMETRIAL CANCER PATIENTS;RECURRENT ENDOMETRIAL CANCER (ATTEND) | 34 | 2022.6 | |
| 6 | PHASE 3 ECZTRA 6 RANDOMIZED CLINICAL TRIAL;PHASE 3 RANDOMIZED CLINICAL TRIAL;MODERATE-TO-SEVERE ATOPIC DERMATITIS (JADE MONO-1);MODERATE-TO-SEVERE ATOPIC DERMATITIS (AD UP);TREAT MODERATE-TO-SEVERE ATOPIC DERMATITIS | 33 | 2021.8 | |
| 6 | CHRONIC HEPATITIS B FUNCTIONAL CURE;UNTREATED CHRONIC HEPATITIS B PATIENTS;CHRONIC HEPATITIS B INFECTION;CHRONIC HEPATITIS B BASELINE VIRAL LOAD;HEPATITIS B VIRUS FUNCTIONAL CURE | 33 | 2022.9 | |
| 8 | TYPE I IFNS UNDERLIE CRITICAL COVID-19 PNEUMONIA;SEVERE COVID-19 PATIENTS;SEVERE COVID-19 INFECTION;SEVERE COVID-19;HOST FACTORS UNDERLYING CRITICAL COVID-19 | 32 | 2020.4 | |
| 8 | CROSS-REACTIVE SARS-COV-2 T CELL EPITOPES;SARS-COV-2 HUMAN T CELL EPITOPES;SARS-COV-2 SPECIFIC CD8+ T CELL RESPONSES;SARS-COV-2-SPECIFIC T CELL IMMUNITY;CROSS-REACTIVE MEMORY T CELLS ASSOCIATE | 32 | 2020.6 | |
| 10 | SEVERELY ACTIVE CROHNS DISEASE;WITHDRAWAL PHASE 3 FORTIFY MAINTENANCE TRIAL;SEVERELY ACTIVE ULCERATIVE COLITIS (QUASAR);SEVERELY ACTIVE ULCERATIVE COLITIS;MODERATELY-TO-SEVERELY ACTIVE CROHNS DISEASE | 31 | 2022.9 | |
| Clinical Medicine | 1 | EVALUATING GLYMPHATIC SYSTEM FUNCTION;GLYMPHATIC SYSTEM IMPAIRMENT;GLYMPHATIC SYSTEM DYSFUNCTION;GLYMPHATIC SYSTEM ALTERATIONS;IMPAIRED GLYMPHATIC SYSTEM | 47 | 2022.2 |
| 2 | MULTIPLE SEGMENTS (DIMS) SPECTACLE LENSES SLOW MYOPIA PROGRESSION;MYOPIA CONTROL EFFECT;ONE-YEAR MYOPIA CONTROL EFFICACY;MYOPIA PROGRESSION (LAMP);MYOPIA CONTROL | 46 | 2021.9 | |
| 3 | MONKEYPOX VIRUS (MPXV) 2022 OUTBREAK;CONFIRMED HUMAN MONKEYPOX VIRUS CASES;HUMAN MONKEYPOX VIRUS INFECTION;ONGOING MONKEYPOX VIRUS OUTBREAK;MONKEYPOX VIRUS OUTBREAK | 45 | 2022.6 | |
| 4 | HEART FAILURE PATIENTS;ACUTE DECOMPENSATED HEART FAILURE (EMPA-RESPONSE-AHF);ACUTE DECOMPENSATED HEART FAILURE (EMPAG-HF);ACUTE DECOMPENSATED HEART FAILURE;ACUTE HEART FAILURE | 44 | 2021.5 | |
| 5 | MITOCHONDRIAL COPPER DEPLETION SUPPRESSES TRIPLE-NEGATIVE BREAST CANCER;COPPER IONOPHORE TARGETING MITOCHONDRIAL METABOLISM;CUPROPTOSIS-PROMOTED CANCER SYNERGISTIC THERAPY;CUPROPTOSIS-BASED SYNERGISTIC CANCER THERAPY;COPPER METABOLISM | 43 | 2022.2 | |
| 6 | PROLONGED HYPOTHERMIC MACHINE PERFUSION ENABLES DAYTIME LIVER TRANSPLANTATION;NORMOTHERMIC MACHINE PERFUSION ENABLES SAFE TRANSPLANTATION;EXTENDED CRITERIA DONOR LIVER TRANSPLANTATION-A RANDOMIZED CLINICAL TRIAL;EXTENDED CRITERIA DONATION LIVER TRANSPLANTATION;HYPOTHERMIC OXYGENATED MACHINE PERFUSION REDUCES EARLY ALLOGRAFT INJURY | 42 | 2022.6 | |
| 7 | YAP1-EXPRESSING SMALL CELL LUNG CANCER CELL LINES LEADS;EXTENSIVE-STAGE SMALL CELL LUNG CANCER (CASPIAN);EXTENSIVE-STAGE SMALL CELL LUNG CANCER;CLINICALLY RELEVANT SMALL CELL LUNG CANCER SUBTYPES;SMALL CELL LUNG CANCER SUBTYPES | 41 | 2022.2 | |
| 8 | GLUCAGON-LIKE PEPTIDE 1 (GLP-1) RECEPTOR AGONISTS;GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS;GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE SEMAGLUTIDE REDUCES ALCOHOL DRINKING;GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS);GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS | 40 | 2023.9 | |
| 8 | CARFILZOMIB PLUS LENALIDOMIDE;LOW-DOSE DEXAMETHASONE;RELAPSED MULTIPLE MYELOMA (IKEMA);REFRACTORY MULTIPLE MYELOMA (CANDOR);RELAPSED MULTIPLE MYELOMA | 40 | 2022.3 | |
| 8 | RESPIRATORY SYNCYTIAL VIRUS LOWER RESPIRATORY TRACT INFECTIONS;RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F PROTEIN VACCINE (RSVPREF3 OA);RESPIRATORY SYNCYTIAL VIRUS PREFUSION F PROTEIN VACCINE;PREFUSION F PROTEIN-BASED RESPIRATORY SYNCYTIAL VIRUS IMMUNIZATION;RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED ACUTE RESPIRATORY INFECTION | 40 | 2023 | |
| 8 | ELEVATED REMNANT CHOLESTEROL;HIGH CARDIOVASCULAR RISK;ELEVATED LDL CHOLESTEROL (ORION-3);ELEVATED LDL CHOLESTEROL;REDUCE CARDIOVASCULAR RISK | 40 | 2022.1 | |
| 8 | OPERABLE STAGE IIIA NON-SMALL-CELL LUNG CANCER (NADIM PHASE II TRIAL);STAGE IIIA(N2) NON-SMALL-CELL LUNG CANCER-A MULTICENTER SINGLE-ARM PHASE II TRIAL;RESECTED STAGE II-IIIA NON-SMALL-CELL LUNG CANCER (IMPOWER010);RESECTED EGFR-MUTATED STAGE IB-IIIA NON-SMALL-CELL LUNG CANCER;RESECTED STAGE IB-IIIA NON-SMALL-CELL LUNG CANCER (IMPOWER010) | 40 | 2022.4 | |
| Psychiatry/Psychology | 1 | UK COVID-19 MENTAL HEALTH & WELLBEING;EARLY COVID-19 PANDEMIC;COVID-19 PANDEMIC LOCKDOWNS;COVID-19 PANDEMIC;COVID-19 PSYCHOLOGICAL WELLBEING | 47 | 2020.9 |
| 2 | PHYSICAL ACTIVITY MODERATED;SOCIAL NETWORK SITE ADDICTION;PHYSICAL ACTIVITY INTERVENTIONS;SOCIAL NETWORK SITES ADDICTION;SOCIAL NETWORK ADDICTION | 45 | 2024.3 | |
| 3 | GLUCAGON-LIKE PEPTIDE 1 (GLP-1) RECEPTOR AGONISTS;GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS;GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE SEMAGLUTIDE REDUCES ALCOHOL DRINKING;GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS);GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS | 40 | 2023.9 | |
| 4 | AI-POWERED VIRTUAL INFLUENCERS OUTPERFORM HUMAN INFLUENCERS;EXAMINING VIRTUAL INFLUENCERS BRAND ENDORSEMENT EFFECTIVENESS;VIRTUAL INFLUENCERS TRIGGER CONSUMER ENGAGEMENT;VIRTUAL INFLUENCERS FORM REALISM;STEREOTYPING HUMAN-LIKE VIRTUAL INFLUENCERS | 37 | 2023.1 | |
| 5 | AUTISM RESEARCH;AUTISM;AUTISM RESEARCH PRIORITIES;AUTISM EARLY INTERVENTION RESEARCH;AUTISM RESEARCH | 35 | 2021.5 | |
| 6 | HUMAN BRAIN NETWORKS;LOCAL DYNAMIC SPONTANEOUS BRAIN ACTIVITY CHANGES;MACROSCALE BRAIN NETWORKS;GLOBAL BRAIN DISORDER;BRAIN MAPS | 34 | 2021.5 | |
| 7 | UNPACKING CHINESE EFL STUDENTS ACADEMIC ENGAGEMENT;FOSTER CHINESE EFL STUDENTS ACADEMIC ENGAGEMENT;EXPLORING CHINESE EFL LEARNERS ENGAGEMENT;EFL STUDENTS ACADEMIC ENGAGEMENT;CHINESE EFL TEACHERS PERCEPTIONS | 33 | 2024 | |
| 8 | EXPLORING GENDER BIAS;GENDER INEQUALITY;GENDER BIAS;PARENTHOOD IMPACT ACADEMIC PRODUCTIVITY;ENSURE GENDER EQUITY | 27 | 2021.3 | |
| 9 | NATIONAL SLEEP FOUNDATION SLEEP TIMING;MEETING 24-H MOVEMENT BEHAVIOR GUIDELINES;MEETING 24-HOUR MOVEMENT GUIDELINES;MODERATE-TO-HIGH INTENSITY PHYSICAL ACTIVITY;PHYSICAL ACTIVITY | 26 | 2022.1 | |
| 9 | WEIGHT-ADJUSTED WAIST INDEX REFLECTS FAT;BODY ROUNDNESS INDEX TRAJECTORIES;BODY ROUNDNESS INDEX (BRI);WEIGHT-ADJUSTED WAIST INDEX;BODY ROUNDNESS INDEX | 26 | 2023.2 | |
| Environment/Ecology | 1 | RESONANCE LEVEL ENABLES HIGH THERMOELECTRIC PERFORMANCE;HIGH THERMOELECTRIC PERFORMANCE REALIZED;HIGH THERMOELECTRIC PERFORMANCE;EXTRAORDINARILY HIGH AVERAGE THERMOELECTRIC FIGURE;HIGH THERMOELECTRIC EFFICIENCY REALIZED | 42 | 2023.2 |
| 2 | ECONOMIC ENERGY MANAGEMENTOF NETWORKED FLEXI-RENEWABLE ENERGY HUBS;ENERGY MANAGEMENT SYSTEM BASED;RENEWABLE ENERGY SOURCES BASED;RENEWABLE ENERGY SYSTEM;GRID-CONNECTED RENEWABLE ENERGY HUBS INCLUDING FLEXIBLE SOURCES | 40 | 2022.6 | |
| 3 | ELECTRO-DRIVEN DIRECT LITHIUM EXTRACTION;LITHIUM EXTRACTION TECHNOLOGIES;DIRECT LITHIUM EXTRACTION;HIGH-PERMEANCE LITHIUM SEPARATION MEMBRANES;SOLAR TRANSPIRATION-POWERED LITHIUM EXTRACTION | 39 | 2022.6 | |
| 4 | TIRE RUBBER-DERIVED CONTAMINANT 6PPDQ-INDUCED ACUTE TOXICITY;TIRE RUBBER-DERIVED CHEMICAL 6PPD-QUINONE;TIRE RUBBER-DERIVED CONTAMINANT 6PPD-QUINONE IMPAIRS SPERM QUALITY;TIRE RUBBER-DERIVED CONTAMINANT 6PPD;TIRE WEAR COMPOUNDS 6PPD-QUINONE | 37 | 2022.7 | |
| 5 | SOIL HEAVY METAL POLLUTION;SOIL HEAVY METALS;AGRICULTURAL SOIL HEAVY METAL CONTENTS;SOIL HEAVY METAL CONTAMINATION;HUMAN HEALTH RISK ASSESSMENT | 35 | 2021.3 | |
| 6 | MOLECULAR TRAP ENGINEERING ENABLES SUPERIOR HIGH-TEMPERATURE CAPACITIVE ENERGY STORAGE PERFORMANCE;SUPERIOR HIGH-TEMPERATURE CAPACITIVE ENERGY STORAGE;HIGH-TEMPERATURE CAPACITIVE ENERGY STORAGE;HIGH-TEMPERATURE DIELECTRIC ENERGY STORAGE;HIGH-TEMPERATURE ENERGY STORAGE DIELECTRICS | 34 | 2021.9 | |
| 6 | BIOCHAR PHYSICOCHEMICAL PROPERTIES;BIOCHAR PROPERTIES;SOIL ORGANIC CARBON MINERALIZATION DEPEND;CROP RESIDUE BIOCHAR;SOIL PHYSICOCHEMICAL PROPERTIES | 34 | 2021.4 | |
| 6 | IMPLEMENTING BUILDING-LEVEL SARS-COV-2 WASTEWATER SURVEILLANCE;WASTEWATER ANTICIPATED COVID-19 OCCURRENCE;SARS-COV-2 RNA MONITORING;EARLY-PANDEMIC WASTEWATER SURVEILLANCE;WASTEWATER SURVEILLANCE | 34 | 2020.4 | |
| 9 | LOCKDOWN AMID COVID-19 PANDEMIC;COVID-19 LOCKDOWN EFFECTS;COVID-19 PARTIAL LOCKDOWN;LOCKDOWN REDUCE AIR POLLUTION;COVID-19 STRICT LOCKDOWN | 33 | 2020.1 | |
| 10 | ECONOMIC GROWTH AMID ENVIRONMENTAL SUSTAINABILITY;ABUNDANT ENERGY RESOURCES;SUSTAINABLE ENERGY POLICY;ENERGY RESOURCES;NUCLEAR ENERGY CONSUMPTION | 32 | 2022 | |
| Chemistry | 1 | RECHARGEABLE HIGH-ENERGY HYBRID ZINC-IODINE AQUEOUS BATTERIES EXPLOITING REVERSIBLE CHLORINE-BASED REDOX REACTION;AQUEOUS RECHARGEABLE ZINC-IODINE BATTERIES;IODINE SPECIES ENABLES SHUTTLE-FREE ZINC-IODINE BATTERIES;STABILIZE AQUEOUS ZINC-IODINE BATTERIES;AQUEOUS ZINC-IODINE BATTERIES | 48 | 2023.2 |
| 1 | FACILITATING EFFICIENT PHOTOCATALYTIC HYDROGEN EVOLUTION;EFFICIENT PHOTOCATALYTIC HYDROGEN EVOLUTION;EFFICIENT PHOTOCATALYTIC HYDROGEN PRODUCTION;GRAPHDIYNE (CNH2N-2) BASED CUI-GDY/ZNAL LDH DOUBLE S-SCHEME HETEROJUNCTION PROVED WITH<I> IN</I><I> SITU</I> XPS;EFFICIENTLY PHOTOCATALYTIC HYDROGEN EVOLUTION | 48 | 2023.1 | |
| 1 | VARIATIONAL QUANTUM MACHINE LEARNING;TRAINING VARIATIONAL QUANTUM ALGORITHMS;TRAINING DEEP QUANTUM NEURAL NETWORKS;QUANTUM ERROR MITIGATION;VARIATIONAL QUANTUM ALGORITHMS | 48 | 2021.6 | |
| 4 | MACHINE LEARNING OPTIMIZED OPTICAL SURFACE PLASMON RESONANCE BIOSENSOR;THZ METASURFACE-ENABLED MACHINE LEARNING OPTIMIZED SURFACE PLASMON RESONANCE SENSOR;MACHINE LEARNING-ENHANCED SURFACE PLASMON RESONANCE DETECTION;GRAPHENE-ENHANCED TERAHERTZ METASURFACES SURFACE PLASMON RESONANCE BIOSENSOR;GRAPHENE-BASED SURFACE PLASMON RESONANCE METASURFACES TERAHERTZ SENSOR | 47 | 2024.7 | |
| 4 | BIMETALLIC METAL-ORGANIC FRAMEWORKS (BMOFS);BIMETALLIC METAL-ORGANIC FRAMEWORKS;METAL-ORGANIC FRAMEWORKS (MOFS);METAL-ORGANIC FRAMEWORK-BASED SUPERCAPACITOR ELECTRODE MATERIALS;MULTICOMPONENT ISORETICULAR METAL-ORGANIC FRAMEWORKS | 47 | 2022.6 | |
| 6 | 1;CATALYTIC FORMAL [2Π+2Σ] CYCLOADDITION;1;LEWIS ACID CATALYZED CYCLOADDITION;ENANTIOSELECTIVE FORMAL (3+3) CYCLOADDITION | 46 | 2023.5 | |
| 6 | MIXED POLYOLEFIN PLASTIC WASTE;POLYPROPYLENE PLASTIC WASTE CONVERSION;CONVERTING WASTE PET PLASTICS;MIXED PLASTICS WASTES UPCYCLING;CONVERTING AROMATIC PLASTIC WASTE BACK | 46 | 2022.1 | |
| 8 | NICO-LDH ENABLES HIGH-PERFORMANCE HYBRID SUPERCAPACITORS;HIGH-PERFORMANCE HYBRID SUPERCAPACITORS;HIGH-PERFORMANCE ASYMMETRIC SUPERCAPACITORS ASSEMBLED;ADVANCED HYBRID SUPERCAPACITORS ASSEMBLED;ADVANCED HYBRID SUPERCAPACITORS | 45 | 2022.9 | |
| 9 | SUSTAINABLE BIODIESEL PRODUCTION;CATALYTIC BIODIESEL PRODUCTION;EFFICIENT BIODIESEL PRODUCTION;MICROWAVE-ASSISTED BIODIESEL PRODUCTION;GREEN BIODIESEL PRODUCTION | 44 | 2022.8 | |
| 10 | EFFICIENT TOXIC DYE REMOVAL;SUSTAINABLE TOXIC DYES REMOVAL;LIGAND BASED SUSTAINABLE COMPOSITE MATERIAL;SPECIFIC LIGAND-BASED FACIAL COMPOSITE ADSORBENT;SUSTAINABLE LIGAND-MODIFIED BASED COMPOSITE MATERIAL | 43 | 2021.8 | |
| 10 | CHIRAL PHOSPHORIC ACID-CATALYZED ASYMMETRIC DEAROMATIZATION REACTIONS;CATALYTIC ASYMMETRIC SYNTHESIS;ORGANOCATALYTIC ASYMMETRIC SYNTHESIS;ORGANOCATALYTIC ASYMMETRIC DEAROMATIZATION REACTIONS;ASYMMETRIC PHOTOCHEMICAL SYNTHESIS | 43 | 2021.7 | |
| Engineering | 1 | MULTI-RESONATOR T-TYPE PHOTOACOUSTIC CELL BASED PHOTOACOUSTIC SPECTROSCOPY GAS SENSOR;HIGHLY SENSITIVE LASER SPECTROSCOPY SENSING BASED;PHOTOACOUSTIC SPECTROSCOPY SENSING BASED;HIGHLY SENSITIVE PHOTOACOUSTIC ACETYLENE DETECTION BASED;MID-INFRARED ALL-FIBER LIGHT-INDUCED THERMOELASTIC SPECTROSCOPY SENSOR BASED | 50 | 2023.9 |
| 2 | INTELLIGENT REFLECTING SURFACE AIDED MULTIGROUP MULTICAST MISO COMMUNICATION SYSTEMS;INTELLIGENT REFLECTING SURFACE AIDED MISO COMMUNICATION SYSTEMS;INTELLIGENT REFLECTING SURFACE AIDED WIRELESS NETWORK;INTELLIGENT REFLECTING SURFACE ASSISTED MULTIUSER COMMUNICATIONS;INTELLIGENT REFLECTING SURFACE AIDED MIMO COMMUNICATION | 49 | 2020.3 | |
| 3 | MACHINE LEARNING OPTIMIZED OPTICAL SURFACE PLASMON RESONANCE BIOSENSOR;THZ METASURFACE-ENABLED MACHINE LEARNING OPTIMIZED SURFACE PLASMON RESONANCE SENSOR;MACHINE LEARNING-ENHANCED SURFACE PLASMON RESONANCE DETECTION;GRAPHENE-ENHANCED TERAHERTZ METASURFACES SURFACE PLASMON RESONANCE BIOSENSOR;GRAPHENE-BASED SURFACE PLASMON RESONANCE METASURFACES TERAHERTZ SENSOR | 47 | 2024.7 | |
| 4 | NICO-LDH ENABLES HIGH-PERFORMANCE HYBRID SUPERCAPACITORS;HIGH-PERFORMANCE HYBRID SUPERCAPACITORS;HIGH-PERFORMANCE ASYMMETRIC SUPERCAPACITORS ASSEMBLED;ADVANCED HYBRID SUPERCAPACITORS ASSEMBLED;ADVANCED HYBRID SUPERCAPACITORS | 45 | 2022.9 | |
| 4 | NONUNIFORM FUNCTIONALLY GRADED CYLINDRICAL SMALL-SCALE BEAM STRUCTURES;MULTI-SCALE HYBRID LAMINATED NANOCOMPOSITE REINFORCED CIRCULAR/ANNULAR PLATE;MULTILAYER GRAPHENE PLATELETS REINFORCED NANOCOMPOSITE ANNULAR PLATE;NON-UNIFORM FUNCTIONALLY GRADED MICROSCALE CYLINDRICAL STRUCTURES;ROTARY SIZE-DEPENDENT FUNCTIONALLY GRADED MICROSYSTEM | 45 | 2022 | |
| 6 | SUSTAINABLE BIODIESEL PRODUCTION;CATALYTIC BIODIESEL PRODUCTION;EFFICIENT BIODIESEL PRODUCTION;MICROWAVE-ASSISTED BIODIESEL PRODUCTION;GREEN BIODIESEL PRODUCTION | 44 | 2022.8 | |
| 6 | UNDERGROUND POROUS MEDIA HYDROGEN STORAGE;UNDERGROUND HYDROGEN STORAGE (UHS);WORLDWIDE UNDERGROUND HYDROGEN STORAGE OPERATING;UNDERGROUND HYDROGEN STORAGE;GEOLOGICAL HYDROGEN STORAGE | 44 | 2021.7 | |
| 6 | MAGNESIUM ALLOYS WORLDWIDE;HIGH-PERFORMANCE CAST MAGNESIUM RARE-EARTH ALLOYS;HIGH-PRESSURE DIE-CAST MAGNESIUM ALLOYS;MAGNESIUM ALLOYS;WE43 MAGNESIUM ALLOY | 44 | 2022.5 | |
| 9 | FUNCTIONALLY GRADED POROUS BEAMS RESTING;FUNCTIONALLY GRADED CARBON NANOTUBE-REINFORCED COMPOSITE IMPERFECT BEAMS;FUNCTIONALLY GRADED SANDWICH BEAMS;FUNCTIONALLY GRADED CARBON NANOTUBE REINFORCED NANOCOMPOSITE BEAMS;FUNCTIONALLY GRADED POROUS (FGP) BEAMS | 43 | 2023.4 | |
| 9 | ALTERMAGNETIC SPIN SPLITTING EFFECT;ALTERMAGNETIC SPIN SPLITTING;ALTERMAGNETIC BAND SPLITTING;GIANT MOMENTUM-DEPENDENT SPIN SPLITTING;SPIN SPLITTING TORQUE | 43 | 2022.9 | |
| 9 | EFFICIENT TOXIC DYE REMOVAL;SUSTAINABLE TOXIC DYES REMOVAL;LIGAND BASED SUSTAINABLE COMPOSITE MATERIAL;SPECIFIC LIGAND-BASED FACIAL COMPOSITE ADSORBENT;SUSTAINABLE LIGAND-MODIFIED BASED COMPOSITE MATERIAL | 43 | 2021.8 | |
| Molecular Biology & Genetics | 1 | SPATIAL TRANSCRIPTOMICS DATA;SPATIAL TRANSCRIPTOMICS ENABLES PROBABILISTIC INFERENCE;HIGHLY SENSITIVE SPATIAL TRANSCRIPTOMICS;DECONVOLUTE SPATIAL TRANSCRIPTOMICS SPOTS;MICROARRAY-BASED SPATIAL TRANSCRIPTOMICS | 50 | 2021.8 |
| 2 | AGE-RELATED MACULAR DEGENERATION <I>A RANDOMIZED PIVOTAL PHASE 2</I>/<I>3 TRIAL</I>;AGE-RELATED MACULAR DEGENERATION <I>A RANDOMIZED PHASE 2 TRIAL</I>;REPORTING NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DATA CONSENSUS;NEOVASCULAR AGE-RELATED MACULAR DEGENERATION NOMENCLATURE;NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (TENAYA | 46 | 2022.1 | |
| 3 | HEART FAILURE PATIENTS;ACUTE DECOMPENSATED HEART FAILURE (EMPA-RESPONSE-AHF);ACUTE DECOMPENSATED HEART FAILURE (EMPAG-HF);ACUTE DECOMPENSATED HEART FAILURE;ACUTE HEART FAILURE | 44 | 2021.5 | |
| 4 | MITOCHONDRIAL COPPER DEPLETION SUPPRESSES TRIPLE-NEGATIVE BREAST CANCER;COPPER IONOPHORE TARGETING MITOCHONDRIAL METABOLISM;CUPROPTOSIS-PROMOTED CANCER SYNERGISTIC THERAPY;CUPROPTOSIS-BASED SYNERGISTIC CANCER THERAPY;COPPER METABOLISM | 43 | 2022.2 | |
| 5 | YAP1-EXPRESSING SMALL CELL LUNG CANCER CELL LINES LEADS;EXTENSIVE-STAGE SMALL CELL LUNG CANCER (CASPIAN);EXTENSIVE-STAGE SMALL CELL LUNG CANCER;CLINICALLY RELEVANT SMALL CELL LUNG CANCER SUBTYPES;SMALL CELL LUNG CANCER SUBTYPES | 41 | 2022.2 | |
| 6 | OPERABLE STAGE IIIA NON-SMALL-CELL LUNG CANCER (NADIM PHASE II TRIAL);STAGE IIIA(N2) NON-SMALL-CELL LUNG CANCER-A MULTICENTER SINGLE-ARM PHASE II TRIAL;RESECTED STAGE II-IIIA NON-SMALL-CELL LUNG CANCER (IMPOWER010);RESECTED EGFR-MUTATED STAGE IB-IIIA NON-SMALL-CELL LUNG CANCER;RESECTED STAGE IB-IIIA NON-SMALL-CELL LUNG CANCER (IMPOWER010) | 40 | 2022.4 | |
| 6 | CARFILZOMIB PLUS LENALIDOMIDE;LOW-DOSE DEXAMETHASONE;RELAPSED MULTIPLE MYELOMA (IKEMA);REFRACTORY MULTIPLE MYELOMA (CANDOR);RELAPSED MULTIPLE MYELOMA | 40 | 2022.3 | |
| 8 | PREVIOUSLY UNTREATED METASTATIC NONSQUAMOUS NON-SMALL-CELL LUNG CANCER;ADVANCED NONSQUAMOUS NON-SMALL-CELL LUNG CANCER;ADVANCED SQUAMOUS NON-SMALL-CELL LUNG CANCER;MYSTIC PHASE 3 RANDOMIZED CLINICAL TRIAL;METASTATIC NON-SMALL-CELL LUNG CANCER (GEMSTONE-302) | 39 | 2021.7 | |
| 9 | ATRIAL FIBRILLATION CATHETER ABLATION;PAROXYSMAL ATRIAL FIBRILLATION ABLATION;PAROXYSMAL ATRIAL FIBRILLATION RECURRENT ATRIAL ARRHYTHMIA BURDEN;VARIABLE-LOOP BIPHASIC PULSED FIELD ABLATION CATHETER;PULSED FIELD CATHETER ABLATION | 34 | 2022.9 | |
| 10 | CHRONIC HEPATITIS B FUNCTIONAL CURE;UNTREATED CHRONIC HEPATITIS B PATIENTS;CHRONIC HEPATITIS B INFECTION;CHRONIC HEPATITIS B BASELINE VIRAL LOAD;HEPATITIS B VIRUS FUNCTIONAL CURE | 33 | 2022.9 | |
| 10 | PAEDIATRIC MULTISYSTEM INFLAMMATORY SYNDROME TEMPORALLY;PAEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME TEMPORALLY;PAEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME (PIMS-TS);PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME TEMPORALLY;PAEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME | 33 | 2020.5 | |
| 10 | PHASE 3 ECZTRA 6 RANDOMIZED CLINICAL TRIAL;PHASE 3 RANDOMIZED CLINICAL TRIAL;MODERATE-TO-SEVERE ATOPIC DERMATITIS (JADE MONO-1);MODERATE-TO-SEVERE ATOPIC DERMATITIS (AD UP);TREAT MODERATE-TO-SEVERE ATOPIC DERMATITIS | 33 | 2021.8 | |
| Materials Science | 1 | RECHARGEABLE HIGH-ENERGY HYBRID ZINC-IODINE AQUEOUS BATTERIES EXPLOITING REVERSIBLE CHLORINE-BASED REDOX REACTION;AQUEOUS RECHARGEABLE ZINC-IODINE BATTERIES;IODINE SPECIES ENABLES SHUTTLE-FREE ZINC-IODINE BATTERIES;STABILIZE AQUEOUS ZINC-IODINE BATTERIES;AQUEOUS ZINC-IODINE BATTERIES | 48 | 2023.2 |
| 1 | FACILITATING EFFICIENT PHOTOCATALYTIC HYDROGEN EVOLUTION;EFFICIENT PHOTOCATALYTIC HYDROGEN EVOLUTION;EFFICIENT PHOTOCATALYTIC HYDROGEN PRODUCTION;GRAPHDIYNE (CNH2N-2) BASED CUI-GDY/ZNAL LDH DOUBLE S-SCHEME HETEROJUNCTION PROVED WITH<I> IN</I><I> SITU</I> XPS;EFFICIENTLY PHOTOCATALYTIC HYDROGEN EVOLUTION | 48 | 2023.1 | |
| 1 | SCALABLE PASSIVE DAYTIME RADIATIVE COOLING;DYNAMICALLY TUNABLE SUBAMBIENT DAYTIME RADIATIVE COOLING METAFABRIC;PASSIVE DAYTIME RADIATIVE COOLING;SUBAMBIENT DAYTIME RADIATIVE COOLING TEXTILE BASED;HIGHLY EFFICIENT ALL-DAY PASSIVE RADIATIVE COOLING | 48 | 2021.7 | |
| 4 | BIMETALLIC METAL-ORGANIC FRAMEWORKS (BMOFS);BIMETALLIC METAL-ORGANIC FRAMEWORKS;METAL-ORGANIC FRAMEWORKS (MOFS);METAL-ORGANIC FRAMEWORK-BASED SUPERCAPACITOR ELECTRODE MATERIALS;MULTICOMPONENT ISORETICULAR METAL-ORGANIC FRAMEWORKS | 47 | 2022.6 | |
| 5 | TOPOLOGICAL KAGOME SUPERCONDUCTOR CSV<SUB>3</SUB>SB<SUB>5</SUB>;TOPOLOGICAL KAGOME METAL CSV<SUB>3</SUB>SB<SUB>5</SUB>;KAGOME SUPERCONDUCTOR CSV<SUB>3</SUB>SB<SUB>5</SUB>;CHARGE-ORDERED KAGOME METAL CSV<SUB>3</SUB>SB<SUB>5</SUB>;KAGOME METAL CSV<SUB>3</SUB>SB<SUB>5</SUB> | 46 | 2021.3 | |
| 5 | MIXED POLYOLEFIN PLASTIC WASTE;POLYPROPYLENE PLASTIC WASTE CONVERSION;CONVERTING WASTE PET PLASTICS;MIXED PLASTICS WASTES UPCYCLING;CONVERTING AROMATIC PLASTIC WASTE BACK | 46 | 2022.1 | |
| 7 | BROADBAND NEAR-INFRARED GARNET PHOSPHORS;CR3+-BASED BROADBAND NEAR-INFRARED LUMINESCENCE;BROADBAND NEAR-INFRARED PHOSPHOR BAMGAL<SUB>10</SUB>O<SUB>17</SUB>;LASER-DRIVEN BROADBAND NEAR-INFRARED LIGHT SOURCE;BROADBAND NEAR-INFRARED LUMINESCENCE | 44 | 2021.9 | |
| 7 | MAGNESIUM ALLOYS WORLDWIDE;HIGH-PERFORMANCE CAST MAGNESIUM RARE-EARTH ALLOYS;HIGH-PRESSURE DIE-CAST MAGNESIUM ALLOYS;MAGNESIUM ALLOYS;WE43 MAGNESIUM ALLOY | 44 | 2022.5 | |
| 9 | ALTERMAGNETIC SPIN SPLITTING EFFECT;ALTERMAGNETIC SPIN SPLITTING;ALTERMAGNETIC BAND SPLITTING;GIANT MOMENTUM-DEPENDENT SPIN SPLITTING;SPIN SPLITTING TORQUE | 43 | 2022.9 | |
| 9 | MITOCHONDRIAL COPPER DEPLETION SUPPRESSES TRIPLE-NEGATIVE BREAST CANCER;COPPER IONOPHORE TARGETING MITOCHONDRIAL METABOLISM;CUPROPTOSIS-PROMOTED CANCER SYNERGISTIC THERAPY;CUPROPTOSIS-BASED SYNERGISTIC CANCER THERAPY;COPPER METABOLISM | 43 | 2022.2 |